Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 171520, 17 pages
http://dx.doi.org/10.1155/2015/171520
Review Article

Glucocorticoid-Induced Tumour Necrosis Factor Receptor-Related Protein: A Key Marker of Functional Regulatory T Cells

Section of Pharmacology, Department of Medicine, University of Perugia, Piazza Severi 1, 06132 Perugia, Italy

Received 8 January 2015; Accepted 18 March 2015

Academic Editor: Xiao-Feng Yang

Copyright © 2015 Simona Ronchetti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, “Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases,” Journal of Immunology, vol. 155, no. 3, pp. 1151–1164, 1995. View at Google Scholar · View at Scopus
  2. D. V. Sawant and D. A. A. Vignali, “Once a Treg, always a Treg?” Immunological Reviews, vol. 259, no. 1, pp. 173–191, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Morikawa and S. Sakaguchi, “Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells,” Immunological Reviews, vol. 259, no. 1, pp. 192–205, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. K. Abbas, C. Benoist, J. A. Bluestone et al., “Regulatory T cells: recommendations to simplify the nomenclature,” Nature Immunology, vol. 14, no. 4, pp. 307–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Croft, “The TNF family in T cell differentiation and function—unanswered questions and future directions,” Seminars in Immunology, vol. 26, pp. 183–190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. D. A. Wainwright, S. Sengupta, Y. Han, and M. S. Lesniak, “Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors,” Neuro-Oncology, vol. 13, no. 12, pp. 1308–1323, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Wang, A. Ioan-Facsinay, E. I. H. van der Voort, T. W. J. Huizinga, and R. E. M. Toes, “Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells,” European Journal of Immunology, vol. 37, no. 1, pp. 129–138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. C. J. Janson, M. E. Winerdal, P. Marits, M. Thörn, R. Ohlsson, and O. Winqvist, “FOXP3 promoter demethylation reveals the committed Treg population in humans,” PLoS ONE, vol. 3, no. 2, Article ID e1612, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. T. J. Curiel, “Tregs and rethinking cancer immunotherapy,” Journal of Clinical Investigation, vol. 117, no. 5, pp. 1167–1174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Nocentini, A. Alunno, M. Petrillo et al., “Expansion of regulatory GITR+ CD25Low/-CD4+ T cells in systemic lupus erythematosus patients,” Arthritis Research & Therapy, vol. 16, article 444, 2014. View at Google Scholar
  11. M. E. Winerdal, P. Marits, M. Winerdal et al., “FOXP3 and survival in urinary bladder cancer,” BJU International, vol. 108, no. 10, pp. 1672–1678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Seddiki, B. Santner-Nanan, J. Martinson et al., “Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells,” Journal of Experimental Medicine, vol. 203, no. 7, pp. 1693–1700, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Haase, M. Starke, K. J. Puan, T. S. Lai, and O. Rotzschke, “Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD,” Immunologic Research, vol. 53, no. 1–3, pp. 200–212, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Marwaha, S. Q. Crome, C. Panagiotopoulos et al., “Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes,” Journal of Immunology, vol. 185, no. 7, pp. 3814–3818, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Sakaguchi, D. A. A. Vignali, A. Y. Rudensky, R. E. Niec, and H. Waldmann, “The plasticity and stability of regulatory T cells,” Nature Reviews Immunology, vol. 13, no. 6, pp. 461–467, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. G. Roncarolo, S. Gregori, R. Bacchetta, and M. Battaglia, “Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications,” in Interleukin-10 in Health and Disease, vol. 380 of Current Topics in Microbiology and Immunology, pp. 39–68, Springer, Berlin, Germany, 2014. View at Publisher · View at Google Scholar
  17. R. Bacchetta, E. Gambineri, and M.-G. Roncarolo, “Role of regulatory T cells and FOXP3 in human diseases,” Journal of Allergy and Clinical Immunology, vol. 120, no. 2, pp. 227–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Valzasina, S. Piconese, C. Guiducci, and M. P. Colombo, “Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent,” Cancer Research, vol. 66, no. 8, pp. 4488–4495, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. L. Geiger and S. Tauro, “Nature and nurture in Foxp3+ regulatory T cell development, stability, and function,” Human Immunology, vol. 73, no. 3, pp. 232–239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Nocentini and C. Riccardi, “GITR: a modulator of immune response and inflammation,” Advances in Experimental Medicine and Biology, vol. 647, pp. 156–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. D. L. Clouthier and T. H. Watts, “Cell-specific and context-dependent effects of GITR in cancer, autoimmunity, and infection,” Cytokine and Growth Factor Reviews, vol. 25, no. 2, pp. 91–106, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. D. A. Schaer, J. T. Murphy, and J. D. Wolchok, “Modulation of GITR for cancer immunotherapy,” Current Opinion in Immunology, vol. 24, no. 2, pp. 217–224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Ronchetti, G. Nocentini, C. Riccardi, and P. P. Pandolfi, “Role of GITR in activation response of T lymphocytes,” Blood, vol. 100, no. 1, pp. 350–352, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Ronchetti, O. Zollo, S. Bruscoli et al., “Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations,” European Journal of Immunology, vol. 34, no. 3, pp. 613–622, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Kanamaru, P. Youngnak, M. Hashiguchi et al., “Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells,” Journal of Immunology, vol. 172, no. 12, pp. 7306–7314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi, “Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance,” Nature Immunology, vol. 3, no. 2, pp. 135–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Uraushihara, T. Kanai, K. Ko et al., “Regulation of murine inflammatory bowel disease by CD25+ and CD25 CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells,” The Journal of Immunology, vol. 171, pp. 708–716, 2003. View at Publisher · View at Google Scholar
  28. M. Ono, J. Shimizu, Y. Miyachi, and S. Sakaguchi, “Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related proteinhigh, Foxp3-expressing CD25+ and CD25 regulatory T cells,” Journal of Immunology, vol. 176, no. 8, pp. 4748–4756, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Bianchini, O. Bistoni, A. Alunno et al., “CD4+CD25lowGITR+ cells: a novel human CD4+ T-cell population with regulatory activity,” European Journal of Immunology, vol. 41, no. 8, pp. 2269–2278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Li, S. P. Mahesh, B. J. Kim, R. R. Buggage, and R. B. Nussenblatt, “Expression of Glucocorticoid Induced TNF Receptor Family Related Protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis,” Journal of Autoimmunity, vol. 21, no. 1, pp. 83–92, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. L. M. Snell, A. J. McPherson, G. H. Y. Lin et al., “CD8 T cell-intrinsic GITR is required for T cell clonal expansion and mouse survival following severe influenza infection,” The Journal of Immunology, vol. 185, no. 12, pp. 7223–7234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Nocentini, L. Giunchi, S. Ronchetti et al., “A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 12, pp. 6216–6221, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Kwon, K.-Y. Yu, J. Ni et al., “Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand,” The Journal of Biological Chemistry, vol. 274, no. 10, pp. 6056–6061, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. M. E. Wortzman, D. L. Clouthier, A. J. McPherson, G. H. Y. Lin, and T. H. Watts, “The contextual role of TNFR family members in CD8+ T-cell control of viral infections,” Immunological Reviews, vol. 255, no. 1, pp. 125–148, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. S. McHugh, M. J. Whitters, C. A. Piccirillo et al., “CD4+CD25+ Immunoregulatory T Cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor,” Immunity, vol. 16, no. 2, pp. 311–323, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. L. T. Krausz, R. Bianchini, S. Ronchetti, K. Fettucciari, G. Nocentini, and C. Riccardi, “GITR-GITRL system, a novel player in shock and inflammation,” TheScientificWorldJournal, vol. 7, pp. 533–566, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. P. M. Lacal, M. G. Petrillo, F. Ruffini et al., “Glucocorticoid-induced tumor necrosis factor receptor family-related ligand triggering upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and promotes leukocyte adhesion,” Journal of Pharmacology and Experimental Therapeutics, vol. 347, no. 1, pp. 164–172, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Azuma, “Role of the glucocorticoid-induced TNFR-related protein (GITR)-GITR ligand pathway in innate and adaptive immunity,” Critical Reviews in Immunology, vol. 30, no. 6, pp. 547–557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Howie, H. G. Rueda, M. H. Brown, and H. Waldmann, “Secreted and transmembrane 1A is a novel co-stimulatory ligand,” PLoS ONE, vol. 8, no. 9, Article ID e73610, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Tone, Y. Tone, E. Adams et al., “Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 15059–15064, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. G. L. Stephens, R. S. McHugh, M. J. Whitters et al., “Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells,” The Journal of Immunology, vol. 173, no. 8, pp. 5008–5020, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. E. M. Esparza and R. H. Arch, “Glucocorticoid-induced TNF receptor functions as a costimulatory receptor that promotes survival in early phases of T cell activation,” Journal of Immunology, vol. 174, no. 12, pp. 7869–7874, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. A. P. Kohm, J. S. Williams, and S. D. Miller, “Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis,” Journal of Immunology, vol. 172, no. 8, pp. 4686–4690, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Santucci, M. Agostini, S. Bruscoli et al., “GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice,” Gut, vol. 56, no. 1, pp. 52–60, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Cuzzocrea, E. Ayroldi, R. Di Paola et al., “Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis,” The FASEB Journal, vol. 19, no. 10, pp. 1253–1265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Cuzzocrea, G. Nocentini, R. Di Paola et al., “Proinflammatory role of glucocorticoid-induced TNF receptor-related gene in acute lung inflammation,” Journal of Immunology, vol. 177, no. 1, pp. 631–641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Calmels, S. Paul, N. Futin, C. Ledoux, F. Stoeckel, and B. Acres, “Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L,” Cancer Gene Therapy, vol. 12, no. 2, pp. 198–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Zhou, L. L'Italien, D. Hodges, and X. M. Schebye, “Pivotal roles of CD4+ effector T cells in mediating agonistic anti-GITR mAb-induced-immune activation and tumor immunity in CT26 tumors,” Journal of Immunology, vol. 179, no. 11, pp. 7365–7375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. N. van der Werf, S. A. Redpath, A. T. Phythian-Adams et al., “Th2 responses to helminth parasites can be therapeutically enhanced by, but are not dependent upon, GITR-GITR ligand costimulation in vivo,” Journal of Immunology, vol. 187, no. 3, pp. 1411–1420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. A. D. Cohen, A. Diab, M.-A. Perales et al., “Agonist anti-GITR antibody enhances vaccine-induced CD8+ T-cell responses and tumor immunity,” Cancer Research, vol. 66, no. 9, pp. 4904–4912, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Galuppo, G. Nocentini, E. Mazzon et al., “GITR gene deletion and gitr-fc soluble protein administration inhibit multiple organ failure induced by zymosan,” Shock, vol. 36, no. 3, pp. 263–271, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Nocentini, S. Cuzzocrea, T. Genovese et al., “Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury,” Molecular Pharmacology, vol. 73, no. 6, pp. 1610–1621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Yamagiwa, S. Fukunishi, T. Tachibana, H. Okamura, S. Yoshiya, and S.-I. Kashiwamura, “Abrogation of Treg function deteriorates rheumatoid arthritis,” Modern Rheumatology, vol. 22, no. 1, pp. 80–88, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. B. Moradi, P. Schnatzer, S. Hagmann et al., “CD4+CD25+/highCD127low/- regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints-analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood,” Arthritis Research and Therapy, vol. 16, no. 2, article R97, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Sun, N. Yu, X. Li et al., “Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus,” International Journal of Rheumatic Diseases, 2014. View at Publisher · View at Google Scholar
  56. D. Mesquita Jr., W. M. Cruvinel, J. A. Araujo, K. C. Salmazi, E. G. Kallas, and L. E. Andrade, “Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus,” Brazilian Journal of Medical and Biological Research, vol. 47, pp. 662–669, 2014. View at Google Scholar
  57. A. Alunno, G. Nocentini, O. Bistoni et al., “Expansion of CD4+CD25-GITR+ regulatory t-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity,” Reumatismo, vol. 64, no. 5, pp. 293–298, 2012. View at Google Scholar · View at Scopus
  58. A. Alunno, M. G. Petrillo, G. Nocentini et al., “Characterization of a new regulatory CD4+ T cell subset in primary sjögren's syndrome,” Rheumatology, vol. 52, no. 8, Article ID ket179, pp. 1387–1396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. X. Gan, X. Feng, L. Gu et al., “Correlation of increased blood levels of GITR and GITRL with disease severity in patients with primary Sjögren's syndrome,” Clinical and Developmental Immunology, vol. 2013, Article ID 340751, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Xufré, M. Costa, C. Roura-Mir et al., “Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients,” International Immunology, vol. 25, no. 10, pp. 563–574, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Chen, G. Chen, S. Deng, X. Liu, G. J. Hutton, and J. Hong, “IFN-beta induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis,” Journal of Neuroimmunology, vol. 242, no. 1-2, pp. 39–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Raedler, S. Illi, L. A. Pinto et al., “IL10 polymorphisms influence neonatal immune responses, atopic dermatitis, and wheeze at age 3 years,” Journal of Allergy and Clinical Immunology, vol. 131, no. 3, pp. 789–796, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. V. I. Casaca, S. Illi, E. Klucker et al., “STAT6 polymorphisms are associated with neonatal regulatory T cells and cytokines and atopic diseases at 3 years,” Allergy, vol. 68, no. 10, pp. 1249–1258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Pietruczuk, M.-O. Eusebio, L. Kraszula, M. Kupczyk, and P. Kuna, “Phenotypic characterization of ex vivo CD4+CD25highCD127low immune regulatory T cells in allergic asthma: pathogenesis relevance of their FoxP3, GITR, CTLA-4 and FAS expressions,” Journal of Biological Regulators and Homeostatic Agents, vol. 26, no. 4, pp. 627–639, 2012. View at Google Scholar · View at Scopus
  65. F. F. Ni, C. R. Li, Q. Li, Y. Xia, G. B. Wang, and J. Yang, “Regulatory T cell microRNA expression changes in children with acute Kawasaki disease,” Clinical & Experimental Immunology, vol. 178, pp. 384–393, 2014. View at Google Scholar
  66. N. Arandi, A. Mirshafiey, M. Jeddi-Tehrani et al., “Alteration in frequency and function of CD4+CD25+FOXP3+ regulatory T cells in patients with immune thrombocytopenic purpura,” Iranian Journal of Allergy, Asthma, and Immunology, vol. 13, no. 2, pp. 85–92, 2014. View at Google Scholar
  67. A. Lluis, N. Ballenberger, S. Illi et al., “Regulation of TH17 markers early in life through maternal farm exposure,” Journal of Allergy and Clinical Immunology, vol. 133, no. 3, pp. 864–871, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. P.-L. Chan, J. Zheng, Y. Liu et al., “TLR5 signaling enhances the proliferation of human allogeneic CD40-activated B cell induced CD4hiCD25+ regulatory T cells,” PLoS ONE, vol. 8, no. 7, Article ID e67969, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. L. C. Arruda, J. C. Lorenzi, A. P. Sousa et al., “Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients,” Bone Marrow Transplantation, vol. 50, no. 3, pp. 380–389, 2015. View at Publisher · View at Google Scholar
  70. I. Avivi, D. Stroopinsky, J. M. Rowe, and T. Katz, “A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management,” Transplant Immunology, vol. 28, no. 1, pp. 57–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. N. Arandi, A. Mirshafiey, H. Abolhassani et al., “Frequency and expression of inhibitory markers of CD4+CD25+FOXP3+ regulatory T cells in patients with common variable immunodeficiency,” Scandinavian Journal of Immunology, vol. 77, no. 5, pp. 405–412, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Pistulli, S. König, S. Drobnik et al., “Decrease in dendritic cells in endomyocardial biopsies of human dilated cardiomyopathy,” European Journal of Heart Failure, vol. 15, no. 9, pp. 974–985, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Giannopoulos, W. Kaminska, I. Hus, and A. Dmoszynska, “The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma,” British Journal of Cancer, vol. 106, no. 3, pp. 546–552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Feyler, G. B. Scott, C. Parrish et al., “Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent,” PLoS ONE, vol. 7, no. 5, Article ID e35981, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. L. T. Krausz, Z. Z. Major, D. F. Muresanu, E. Chelaru, G. Nocentini, and C. Riccardi, “Characterization of CD4+ and CD8+ tregs in a Hodgkin's lymphoma patient presenting with myasthenia-like symptoms,” Ideggyogyaszati Szemle, vol. 66, no. 9-10, pp. 343–348, 2013. View at Google Scholar · View at Scopus
  76. K. Skórka, N. Bhattacharya, P. Własiuk et al., “Thalidomide regulation of NF-kappaB proteins limits tregs activity in chronic lymphocytic leukemia,” Advances in Clinical and Experimental Medicine, vol. 23, no. 1, pp. 25–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. L. T. Krausz, E. Fischer-Fodor, Z. Z. Major, and B. Fetica, “GITR-expressing regulatory T-cell subsets are increased in tumor-positive lymph nodes from advanced breast cancer patients as compared to tumor-negative lymph nodes,” International Journal of Immunopathology and Pharmacology, vol. 25, no. 1, pp. 59–66, 2012. View at Google Scholar · View at Scopus
  78. L. Benevides, C. R. B. Cardoso, D. G. Tiezzi, H. R. C. Marana, J. M. Andrade, and J. S. Silva, “Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor,” European Journal of Immunology, vol. 43, no. 6, pp. 1518–1528, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Beyer, B. Schumak, M. R. Weihrauch et al., “In vivo expansion of naïve CD4+CD25High FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration,” PLoS ONE, vol. 7, no. 1, Article ID e30422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. C. Vasco, A. Canazza, A. Rizzo et al., “Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study,” Journal of Neuro-Oncology, vol. 115, no. 3, pp. 353–363, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Pedroza-Gonzalez, C. Verhoef, J. N. M. Ijzermans et al., “Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer,” Hepatology, vol. 57, no. 1, pp. 183–194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. E. L. Goode, M. DeRycke, K. R. Kalli et al., “Inherited variants in regulatory T cell genes and outcome of ovarian cancer,” PLoS ONE, vol. 8, no. 1, Article ID e53903, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Yan, Y. Zhang, J.-P. Zhang, J. Liang, L. Li, and L. Zheng, “Tim-3 expression defines regulatory T cells in human tumors,” PLoS ONE, vol. 8, no. 3, Article ID e58006, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. C. T. J. Padovani, C. M. Bonin, I. A. Tozetti, A. M. T. Ferreira, C. E. Dos Santos Fernandes, and I. P. Da Costa, “Glucocorticoid-induced tumor necrosis factor receptor expression in patients with cervical human papillomavirus infection,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 46, no. 3, pp. 288–292, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. G. Méndez-Lagares, M. M. Pozo-Balado, M. Genebat, A. García-Pergañeda, M. Leal, and Y. M. Pacheco, “Severe immune dysregulation affects CD4+CD25 hiFoxP3+ regulatory T cells in HIV-infected patients with low-level CD4 T-Cell repopulation despite suppressive highly active antiretroviral therapy,” Journal of Infectious Diseases, vol. 205, no. 10, pp. 1501–1509, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. Y. Satou, A. Utsunomiya, J. Tanabe, M. Nakagawa, K. Nosaka, and M. Matsuoka, “HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals,” Retrovirology, vol. 9, article 46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  87. S. B. Rathod and A. S. Tripathy, “Hepatitis E rORF2p stimulated and unstimulated peripheral expression profiling in patients with self-limiting hepatitis E infection,” Journal of Immunology Research, vol. 2014, Article ID 565284, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. S. B. Rathod, R. Das, S. Thanapati, V. A. Arankalle, and A. S. Tripathy, “Suppressive activity and altered conventional phenotype markers/mediators of regulatory T cells in patients with self-limiting hepatitis E,” Journal of Viral Hepatitis, vol. 21, no. 2, pp. 141–151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. Y. Y. Jin, X. Wang, J. Du et al., “Epstein-Barr virus induces the differentiation of semi-mature dendritic cells from cord blood monocytes,” Human Immunology, vol. 75, no. 4, pp. 306–316, 2014. View at Publisher · View at Google Scholar
  90. F. Wang, J. Chi, G. Peng et al., “Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection,” Journal of Virology, vol. 88, no. 2, pp. 1011–1024, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. D. Rodriguez-Pinto, A. Navas, V. M. Blanco et al., “Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species,” PLoS Neglected Tropical Diseases, vol. 6, no. 4, Article ID e1627, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. F. Koukouikila-Koussounda, F. Ntoumi, M. Ndounga, H. V. Tong, A.-A. Abena, and T. P. Velavan, “Genetic evidence of regulatory gene variants of the STAT6, IL10R and FOXP3 locus as a susceptibility factor in uncomplicated malaria and parasitaemia in Congolese children,” Malaria Journal, vol. 12, no. 1, article 9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Metenou, Y. I. Coulibaly, D. Sturdevant et al., “Highly heterogeneous, activated, and short-lived regulatory T cells during chronic filarial infection,” European Journal of Immunology, vol. 44, no. 7, pp. 2036–2047, 2014. View at Publisher · View at Google Scholar
  94. W. Zhang, H. Li, H. Bu et al., “Emodin inhibits the differentiation and maturation of dendritic cells and increases the production of regulatory T cells,” International Journal of Molecular Medicine, vol. 29, no. 2, pp. 159–164, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. L. Moreira-Teixeira, M. Resende, O. Devergne et al., “Rapamycin combined with TGF-β converts human invariant NKT Cells into suppressive Foxp3+ regulatory cells,” Journal of Immunology, vol. 188, no. 2, pp. 624–631, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. G. I. Ellis, M. C. Reneer, A. C. Vélez-Ortega, A. McCool, and F. Martí, “Generation of Induced regulatory T cells from primary human naïve and memory T cells,” Journal of Visualized Experiments, no. 62, Article ID e3738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. R. K. C. Venigalla, P. J. Guttikonda, V. Eckstein et al., “Identification of a human Th1-like IFNγ-secreting Treg subtype deriving from effector T cells,” Journal of Autoimmunity, vol. 39, no. 4, pp. 377–387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. Y. Vercoulen, T. Guichelaar, J. Meerding et al., “Application of cultured human regulatory T cells requires preclinical in vivo evaluation,” Journal of Allergy and Clinical Immunology, vol. 129, no. 3, pp. 852.e3–855.e3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Qin, Z. Wen, Y. Zhou et al., “MicroRNA-126 regulates the induction and function of CD4+ Foxp3+ regulatory T cells through PI3K/AKT pathway,” Journal of Cellular and Molecular Medicine, vol. 17, no. 2, pp. 252–264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  100. Z. Li, F. Lin, C. Zhuo et al., “PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation,” The Journal of Biological Chemistry, vol. 289, no. 39, pp. 26872–26881, 2014. View at Publisher · View at Google Scholar
  101. S. J. Muriglan, T. Ramirez-Montagut, O. Alpdogan et al., “GITR activation induces an opposite effect on alloreactive CD4+ and CD8+ T cells in graft-versus-host disease,” Journal of Experimental Medicine, vol. 200, no. 2, pp. 149–157, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. A. P. Kohm, J. R. Podojil, J. S. Williams, J. S. McMahon, and S. D. Miller, “CD28 regulates glucocorticoid-induced TNF receptor family-related gene expression on CD4+ T cells via IL-2-dependent mechanisms,” Cellular Immunology, vol. 235, no. 1, pp. 56–64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Ronchetti, G. Nocentini, R. Bianchini, L. T. Krausz, G. Migliorati, and C. Riccardi, “Glucocorticoid-induced TNFR-related protein lowers the threshold of CD28 costimulation in CD8+ T cells,” Journal of Immunology, vol. 179, no. 9, pp. 5916–5926, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. S. Ronchetti, G. Nocentini, M. G. Petrillo, and C. Riccardi, “CD8+ T cells: GITR matters,” The Scientific World Journal, vol. 2012, Article ID 308265, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  105. G. H. Y. Lin, L. M. Snell, M. E. Wortzman, D. L. Clouthier, and T. H. Watts, “GITR-dependent regulation of 4-1BB expression: implications for t cell memory and anti-4-1BB-induced pathology,” Journal of Immunology, vol. 190, no. 9, pp. 4627–4639, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. L. M. Snell, G. H. Y. Lin, and T. H. Watts, “IL-15-dependent upregulation of GITR on CD8 memory phenotype T cells in the bone marrow relative to spleen and lymph node suggests the bone marrow as a site of superior bioavailability of IL-15,” The Journal of Immunology, vol. 188, no. 12, pp. 5915–5923, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. D. L. Clouthier, A. C. Zhou, and T. H. Watts, “Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC,” Journal of Immunology, vol. 193, no. 10, pp. 5033–5043, 2014. View at Publisher · View at Google Scholar
  108. R. W. van Olffen, N. Koning, K. P. J. M. van Gisbergen et al., “GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo,” The Journal of Immunology, vol. 182, no. 12, pp. 7490–7500, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. Y. Carrier, M. J. Whitters, J. S. Miyashiro et al., “Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cells,” European Journal of Immunology, vol. 42, no. 6, pp. 1393–1404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. C. W. J. Lio and C. S. Hsieh, “A two-step process for thymic regulatory T cell development,” Immunity, vol. 28, no. 1, pp. 100–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. M. A. Burchill, J. Yang, K. B. Vang et al., “Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire,” Immunity, vol. 28, no. 1, pp. 112–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. S. A. Mahmud, L. S. Manlove, H. M. Schmitz et al., “Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells,” Nature Immunology, vol. 15, no. 5, pp. 473–481, 2014. View at Publisher · View at Google Scholar · View at Scopus
  113. G. Nocentini, S. Ronchetti, S. Cuzzocrea, and C. Riccardi, “GITR/GITRL: more than an effector T cell co-stimulatory system,” European Journal of Immunology, vol. 37, no. 5, pp. 1165–1169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. G. Liao, S. Nayak, J. R. Regueiro et al., “GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells,” International Immunology, vol. 22, no. 4, pp. 259–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. M.-G. Roncarolo and M. Battaglia, “Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans,” Nature Reviews Immunology, vol. 7, no. 8, pp. 585–598, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. G. Liao, M. S. O’Keeffe, G. Wang et al., “Glucocorticoid-induced TNF receptor family-related protein ligand is requisite for optimal functioning of regulatory CD4+ T cells,” Frontiers in Immunology, vol. 5, article 35, 2014. View at Publisher · View at Google Scholar
  117. J. D. Kim, B. K. Choi, J. S. Bae et al., “Cloning and characterization of GITR ligand,” Genes and Immunity, vol. 4, no. 8, pp. 564–569, 2003. View at Publisher · View at Google Scholar · View at Scopus
  118. H.-B. Ji, G. Liao, W. A. Faubion et al., “Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression,” The Journal of Immunology, vol. 172, no. 10, pp. 5823–5827, 2004. View at Publisher · View at Google Scholar · View at Scopus
  119. S. P. Mahesh, Z. Li, B. Liu, R. N. Fariss, and R. B. Nussenblat, “Expression of GITR ligand abrogates immunosuppressive function of ocular tissue and differentially modulates inflammatory cytokines and chemokines,” European Journal of Immunology, vol. 36, no. 8, pp. 2128–2138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. J. Shimizu and E. Moriizumi, “CD4+CD25- T cells in aged mice are hyporesponsive and exhibit suppressive activity,” Journal of Immunology, vol. 170, no. 4, pp. 1675–1682, 2003. View at Publisher · View at Google Scholar · View at Scopus
  121. L. Tsaknaridis, L. Spencer, N. Culbertson et al., “Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity,” Journal of Neuroscience Research, vol. 74, no. 2, pp. 296–308, 2003. View at Publisher · View at Google Scholar · View at Scopus
  122. E. M. Shevach and G. L. Stephens, “The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?” Nature Reviews Immunology, vol. 6, no. 8, pp. 613–618, 2006. View at Publisher · View at Google Scholar · View at Scopus
  123. D. C. Gondek, L. F. Lu, S. A. Quezada, S. Sakaguchi, and R. J. Noelle, “Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism,” Journal of Immunology, vol. 174, no. 4, pp. 1783–1786, 2005. View at Publisher · View at Google Scholar · View at Scopus
  124. A. D. Cohen, D. A. Schaer, C. Liu et al., “Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation,” PLoS ONE, vol. 5, no. 5, Article ID e10436, 2010. View at Publisher · View at Google Scholar · View at Scopus
  125. D. A. Schaer, S. Budhu, C. Liu et al., “GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability,” Cancer Immunology Research, vol. 1, no. 5, pp. 320–331, 2013. View at Publisher · View at Google Scholar
  126. A. Joetham, H. Ohnishi, M. Okamoto et al., “Loss of T regulatory cell suppression following signaling through glucocorticoid-induced tumor necrosis receptor (GITR) is dependent on c-Jun N-terminal kinase activation,” The Journal of Biological Chemistry, vol. 287, no. 21, pp. 17100–17108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  127. B. Valzasina, C. Guiducci, H. Dislich, N. Killeen, A. D. Weinberg, and M. P. Colombo, “Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR,” Blood, vol. 105, no. 7, pp. 2845–2851, 2005. View at Publisher · View at Google Scholar · View at Scopus
  128. D. Coe, S. Begom, C. Addey, M. White, J. Dyson, and J.-G. Chai, “Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy,” Cancer Immunology, Immunotherapy, vol. 59, no. 9, pp. 1367–1377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. Y. Bulliard, R. Jolicoeur, M. Windman et al., “Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies,” Journal of Experimental Medicine, vol. 210, no. 9, pp. 1685–1693, 2013. View at Publisher · View at Google Scholar · View at Scopus
  130. A. Ephrem, A. L. Epstein, G. L. Stephens, A. M. Thornton, D. Glass, and E. M. Shevach, “Modulation of Treg cells/T effector function by GITR signaling is context-dependent,” European Journal of Immunology, vol. 43, no. 9, pp. 2421–2429, 2013. View at Publisher · View at Google Scholar · View at Scopus
  131. T. Ramirez-Montagut, A. Chow, D. Hirschhorn-Cymerman et al., “Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity,” The Journal of Immunology, vol. 176, no. 11, pp. 6434–6442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  132. K. Ko, S. Yamazaki, K. Nakamura et al., “Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells,” Journal of Experimental Medicine, vol. 202, no. 7, pp. 885–891, 2005. View at Publisher · View at Google Scholar · View at Scopus
  133. D. Zelenika, E. Adams, S. Humm et al., “Regulatory T cells overexpress a subset of Th2 gene transcripts,” Journal of Immunology, vol. 168, no. 3, pp. 1069–1079, 2002. View at Publisher · View at Google Scholar · View at Scopus
  134. R. Khattri, T. Cox, S.-A. Yasayko, and F. Ramsdell, “An essential role for Scurfin in CD4+CD25+ T regulatory cells,” Nature Immunology, vol. 4, no. 4, pp. 337–342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  135. Y. Tone, Y. Kidani, C. Ogawa et al., “Gene expression in the gitr locus is regulated by NF-κB and Foxp3 through an enhancer,” Journal of Immunology, vol. 192, no. 8, pp. 3915–3924, 2014. View at Publisher · View at Google Scholar · View at Scopus
  136. D. J. Zabransky, C. J. Nirschl, N. M. Durham et al., “Phenotypic and functional properties of Helios + regulatory T cells,” PLoS ONE, vol. 7, no. 3, Article ID e34547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  137. S. Kreiser, J. Eckhardt, C. Kuhnt et al., “Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo,” Immunobiology, vol. 220, no. 2, pp. 270–279, 2015. View at Publisher · View at Google Scholar
  138. H. Asnagli, D. Martire, N. Belmonte et al., “Type 1 regulatory T cells specific for collagen-type II as an efficient cell-based therapy in arthritis,” Acta Veterinaria Scandinavica, vol. 16, article R115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  139. C. T. Mayer, S. Floess, A. M. Baru, K. Lahl, J. Huehn, and T. Sparwasser, “CD8+Foxp3+ T cells share developmental and phenotypic features with classical CD4+Foxp3+ regulatory T cells but lack potent suppressive activity,” European Journal of Immunology, vol. 41, no. 3, pp. 716–725, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. Q. Zou, B. Wu, J. Xue et al., “CD8+ Treg cells suppress CD8+ T cell-responses by IL-10-dependent mechanism during H5N1 influenza virus infection,” European Journal of Immunology, vol. 44, no. 1, pp. 103–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  141. J. Jiang, C. I. Champion, B. Wei, G. Liu, and K. A. Kelly, “CD8+CXCR5+ T cells regulate pathology in the genital tract,” Infectious Diseases in Obstetrics and Gynecology, vol. 2013, Article ID 813238, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  142. N. Kang, L. Tang, X. Li et al., “Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human,” Immunology Letters, vol. 125, no. 2, pp. 105–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. B. O. Lee, J. E. Jones, C. J. Peters et al., “Identification of a unique double-negative regulatory T-cell population,” Immunology, vol. 134, no. 4, pp. 434–447, 2011. View at Publisher · View at Google Scholar · View at Scopus
  144. I. M. De Kleer, L. R. Wedderburn, L. S. Taams et al., “CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis,” Journal of Immunology, vol. 172, no. 10, pp. 6435–6443, 2004. View at Publisher · View at Google Scholar · View at Scopus
  145. S. Makita, T. Kanai, S. Oshima et al., “CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells,” Journal of Immunology, vol. 173, no. 5, pp. 3119–3130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  146. M. Battaglia, S. Gregori, R. Bacchetta, and M.-G. Roncarolo, “Tr1 cells: from discovery to their clinical application,” Seminars in Immunology, vol. 18, no. 2, pp. 120–127, 2006. View at Publisher · View at Google Scholar · View at Scopus
  147. L. Cosmi, F. Liotta, E. Lazzeri et al., “Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes,” Blood, vol. 102, no. 12, pp. 4107–4114, 2003. View at Publisher · View at Google Scholar · View at Scopus
  148. L. Scotto, A. J. Naiyer, S. Galluzzo et al., “Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28 T suppressor cells,” Human Immunology, vol. 65, no. 11, pp. 1297–1306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  149. J. Heikkinen, M. Möttönen, A. Alanen, and O. Lassila, “Phenotypic characterization of regulatory T cells in the human decidua,” Clinical and Experimental Immunology, vol. 136, no. 2, pp. 373–378, 2004. View at Publisher · View at Google Scholar · View at Scopus
  150. M. K. Levings, R. Sangregorio, C. Sartirana et al., “Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells,” Journal of Experimental Medicine, vol. 196, no. 10, pp. 1335–1346, 2002. View at Publisher · View at Google Scholar · View at Scopus
  151. C. Veldman, A. Pahl, S. Beissert et al., “Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells,” Journal of Immunology, vol. 176, no. 5, pp. 3215–3222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  152. W. Łuczyński, N. Wawrusiewicz-Kurylonek, A. Stasiak-Barmuta et al., “Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes,” Acta Biochimica Polonica, vol. 56, no. 2, pp. 361–370, 2009. View at Google Scholar · View at Scopus
  153. C. Sacchetti, N. Rapini, A. Magrini et al., “In vivo targeting of intratumor regulatory T cells using peg-modified single-walled carbon nanotubes,” Bioconjugate Chemistry, vol. 24, no. 6, pp. 852–858, 2013. View at Publisher · View at Google Scholar · View at Scopus
  154. L. Strauss, C. Bergmann, M. Szczepanski, W. Gooding, J. T. Johnson, and T. L. Whiteside, “A unique subset of CD4+CD25highFoxp3+T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment,” Clinical Cancer Research, vol. 13, no. 15, pp. 4345–4354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  155. B. H. A. von Rahden, S. Kircher, M. Kafka et al., “Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa,” Cancer Biomarkers, vol. 7, no. 6, pp. 285–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  156. A. Alunno, G. Nocentini, O. Bistoni et al., “Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity,” Reumatismo, vol. 64, no. 5, pp. 293–298, 2012. View at Google Scholar · View at Scopus